Thought Leadership Archives - Page 6 of 33

On Demand: NICE Early Scientific Advice: When, Why, and How!

Lisa Lewin2023-11-09T13:07:59+00:00Events, Thought Leadership|

Have you considered using NICE Scientific Advice (SA) to inform your evidence development, trial design, and/or economic modelling? Are you familiar with the concept of NICE SA, but have no direct experience? Or have you used the process before, but want to learn how to optimise your use of it?

Join PRECISIONadvisors on July 26 at 9am EST for a complimentary webinar, as we share our experience with NICE SA in a pragmatic discussion of what it can do for you, and best practices for getting the most from NICE SA.

(more…)

Article: Innovation in Gene Therapies

Lisa Lewin2023-07-14T13:44:43+00:00Thought Leadership|

Despite innovation to date in gene therapy, safety concerns with adeno-associated virus (AAV) vectors and uneasiness around cost and affordability has brought into focus the need for even more advancement in the field. In this Pharma Live article Precision’s Phil Cyr discusses some of the innovations that are occurring to address these issues.

READ THE ARTICLE HERE!

On Demand: Consequences of the IRA on Oncology Care Providers

Lisa Lewin2023-11-20T17:49:13+00:00Events, Thought Leadership|

The goal of this complimentary webinar is to increase understanding of how the IRA impacts your customers…viewing it through their eyes. You will gain insights from experts representing both provider and policy perspectives as they discuss:

What portions of the IRA are important to oncology?
What are the possible positive, negative, and unintended consequences of the IRA?
How are community practices and hospital outpatient departments preparing?
What is the operational impact of IRA?
What role if any should the pharmaceutical company play?

(more…)

White Paper: Moving CGTx Clinical Development Forward in 2023

Lisa Lewin2023-07-12T15:41:04+00:00Thought Leadership|

Clinical trials are foundational to developing innovative, life-saving treatments and cures for patients. For developers of cell and gene therapy (CGTx) products, the path to clinical success is fraught with vast and complex challenges. The CGTx field is becoming more crowded, with increased clinical trial volume and an influx of less-experienced sponsors contributing to an increase in clinical holds in the category. Such challenges intensify the pressure to succeed in a fiercely competitive environment.

(more…)

White Paper: Market Trends and Expectations for Advanced Therapies in 2023

Lisa Lewin2023-07-07T14:29:06+00:00Thought Leadership|

The cell and gene therapy space has undergone transformational change in the last few years, driven by the promise these modalities have demonstrated in addressing rare and intractable diseases. Achievements in the CAR-T therapy space – there are now six approved CAR-T treatments on the market – in conjunction with breakthroughs in gene therapy and viral vector drugs, have signaled a new era of innovation aimed at furthering cell and gene therapies within the greater healthcare landscape.

This white paper is based on a panel discussion hosted by Precision ADVANCE, experts from across the cell and gene therapy sector convened to explore the ways their organizations have met headlong the challenges and opportunities that typify cell and gene therapy development. Panelists for the event included:

Andy Kinley, Vice President, Innovation and Clinical Science, Precision for Medicine
Peter Andersen, Chief Scientific Officer, Vita Therapeutics
Deborah Phippard, Chief Scientific Officer, Precision for Medicine
Palani Palaniappan, Chief Technology Officer, Pioneering Medicines, Flagship Pioneering
Phil Cyr, Senior Vice President, Precision Value & Health
Charlie Harper, Vice President, Project Farma

Download Now!

White Paper: Gene Editing Breakthroughs: A New Hope for Patients

Lisa Lewin2023-06-22T21:46:36+00:00Thought Leadership|

Gene editing technology has rapidly evolved over the past decade. From the initial breakthrough of sequencing the first human genome to researchers today having the ability to create genetically modified mice in as little as four weeks. CRISPR Cas-based gene editing, which acts as a pair of genomic scissors, is at the core of these innovations. The revolutionary technology has enabled rapid genome sequencing and editing to spur advancements in disease research and treatment.

In this white paper, Anshul Mangal President of Project Farma and Precision ADVANCE and Cynthia Pussinen, Advisor & Executive Consulting Partner share how the latest breakthroughs in gene editing technology have the potential to dramatically improve outcomes for patients.

(more…)

Conference: 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit

Lisa Lewin2023-06-18T22:03:59+00:00Events, Thought Leadership|

Precision will be at this year’s 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit, June 20-21, 2023, in Vienna, Austria. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.

Connect with our Advanced Therapy experts!

Schedule a meeting with one our our experts
Be sure to attend Precision’s own, Houria Bachtarzi’s presentation on June 20, 2023, at 10:10 AM CEST

You can register for the 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit below:

REGISTER HERE

(more…)

Download Now: Precision June Events Calendar

Lisa Lewin2023-06-07T18:38:55+00:00Events, Thought Leadership|

The June Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!

See the June events calendar here!

Event: Cell & Gene Reception @ BIO, 2023

Lisa Lewin2023-06-06T19:08:17+00:00Events, Thought Leadership|

Precision is honored to be a co-host of this year’s ARM Cell & Gene Reception @ BIO, May 5, 2023, in Boston, MA. Attendees will enjoy extensive networking opportunities with the sector’s top decision makers including executives from leading companies located in the Boston area!

Connect with our Advanced Therapy experts!